Financial Services
Live Price
Offline$20.59
+0.10% today
1Y Change
-1.34%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Texas Capital Bancshares, Inc. (TCBIO) is a Financial Services stock with a market cap of $4.43B and listed on NASDAQ. The stock last traded around $20.59 and down 1.3% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of +13.5%, EPS growth of +432.6%, a dividend yield of 0.0%. What stands out right now is revenue +13.5%, EPS +432.6%, free cash flow -16.5% with operating margin 23.7% and ROIC 7.4%. Valuation is more restrained than many high-expectation growth names at P/E 12.8 and price/sales 2.2. Stock Foundry combines TCBIO price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TCBIO
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TCBIO Max Drawdown
-10.60%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TCBIO and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$987.1M
-20.7% YoY
FY Net Income
$253.9M
-23.6% YoY
Free Cash Flow
$653.2M
+377.8% YoY
Revenue Growth
+13.5%
EPS Growth
+432.6%
Gross Margin
62.3%
Net Margin
17.7%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2.0B | 1.8B | 1.8B | 1.2B | 987M |
| Gross Profit | 1.2B | 865M | 1.0B | 911M | 909M |
| Operating Income | 444M | 107M | 247M | 432M | 338M |
| EBITDA | 480M | 161M | 287M | 477M | 431M |
| Net Income | 330M | 78M | 189M | 332M | 254M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.9B | 3.2B | 3.2B | 5.0B | 7.9B |
| Total Assets | 31.5B | 30.7B | 28.4B | 28.4B | 34.7B |
| Total Liabilities | 27.9B | 27.4B | 25.2B | 25.4B | 31.5B |
| Shareholder Equity | 3.6B | 3.4B | 3.2B | 3.1B | 3.2B |
| Total Debt | 951M | 1.5B | 2.4B | 2.1B | 3.1B |
| Net Debt | -947M | -1.6B | -884M | -2.9B | -4.8B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
657M
+344.2% YoY
Capital Expenditures
4M
+63.4% YoY
Free Cash Flow
653M
+377.8% YoY
Key ratios
Gross Margin
62.3%
Operating Margin
23.7%
Net Margin
17.7%
ROE
9.9%
Debt / Equity
0.24x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.